Besides, in our results, high expression of CD90, EpCAM, CD133, or CD44 was not significantly correlate with prognosis in HCC, while it was not the same in other papers (Zhao et al., 2016; Hu et al., 2018; Wendum et al., 2018). The gene discussed is CD44; the disease is hepatocellular carcinoma.